Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody

被引:38
作者
Azadmanesh, Kayhan [2 ]
Mohraz, Minoo [3 ]
Aghakhani, Arezoo [1 ]
Edalat, Rozita [2 ]
Jam, Sara [3 ]
Eslamifar, Ali [1 ]
Banifazl, Mohammad [4 ]
Moradmand-Badie, Banafsheh [3 ]
Ramezani, Amitis [1 ]
机构
[1] Pasteur Inst Iran, Dept Clin Res, Tehran 13164, Iran
[2] Pasteur Inst Iran, Dept Virol, Tehran 13164, Iran
[3] Iranian Res Ctr HIV AIDS, Tehran, Iran
[4] Iranian Soc Support Patients Infect Dis, Tehran, Iran
关键词
Human immunodeficiency virus; Hepatitis B virus infection; occult; Hepatitis B core antibody; isolated;
D O I
10.1159/000160217
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Objective: Detection of hepatitis B virus (HBV) DNA without detectable hepatitis B surface antigen (HBsAg) is defined as occult HBV infection. In patients co-infected with human immunodeficiency virus (HIV) and HBV, HIV interferes with the natural history of HBV infection by enhancing HBV replication, leading to more severe liver disease. The aim of this study was to assess occult HBV infection in Iranian HIV-positive patients with isolated hepatitis B core antibody (anti-HBc). Methods: The presence of HBV-DNA was determined quantitatively in plasma samples of HIV-infected patients with isolated anti-HBc by real-time PCR using the artus HBV RG PCR kit on the Rotor-Gene 3000 real-time thermal cycler. Hepatitis C antibody (anti-HCV), alanine aminotransferase (ALT), aspartate aminotransferase (AST), HIV viral load and CD4+ count were also tested in all subjects. Results: Of 106 patients enrolled in this study, 22 subjects ( 20.75%, 95% CI 13-28) had isolated anti-HBc. HBV-DNA was detectable in of the 22 patients (13.6%, 95% CI 0.0-28) who had isolated anti-HBc. Conclusion: A serological profile of isolated anti-HBc could be associated with occult HBV infection in Iranian HIV-infected patients. Therefore the risk of transmission of HBV is probable in these patients. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:270 / 274
页数:5
相关论文
共 34 条
[1]
ENHANCEMENT OF HBSAG DETECTION IN SERUM OF PATIENTS WITH CHRONIC LIVER-DISEASE FOLLOWING REMOVAL OF CIRCULATING IMMUNE-COMPLEXES [J].
ACKERMAN, Z ;
WANDS, JR ;
GAZITT, Y ;
BRECHOT, C ;
KEW, MC ;
SHOUVAL, D .
JOURNAL OF HEPATOLOGY, 1994, 20 (03) :398-404
[2]
Alavian SM, 2007, J GASTROINTEST LIVER, V16, P403
[3]
Occult hepatitis B virus infection: implications in transfusion [J].
Allain, JP .
VOX SANGUINIS, 2004, 86 (02) :83-91
[4]
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].
Bréchot, C ;
Thiers, V ;
Kremsdorf, D ;
Nalpas, B ;
Pol, S ;
Paterlini-Bréchot, P .
HEPATOLOGY, 2001, 34 (01) :194-203
[5]
The clinical significance of surface antigen variants of hepatitis B virus [J].
Carman, WF .
JOURNAL OF VIRAL HEPATITIS, 1997, 4 :11-20
[6]
Occult hepatitis B virus infection: A hidden menace? [J].
Conjeevaram, H ;
Lok, AS .
HEPATOLOGY, 2001, 34 (01) :204-206
[7]
Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy [J].
Filippini, Pietro ;
Coppola, Nicola ;
Pisapia, Raffaella ;
Scolastico, Carlo ;
Marrocco, Cecilia ;
Zaccariello, Antonella ;
Nacca, Cesare ;
Sagnelli, Caterina ;
De Stefano, Giulio ;
Ferraro, Teresa ;
De Stefano, Carlo ;
Sagnelli, Evangelista .
AIDS, 2006, 20 (09) :1253-1260
[8]
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease [J].
Fujiwara, K ;
Tanaka, Y ;
Orito, E ;
Ohno, T ;
Kato, T ;
Sugauchi, F ;
Suzuki, S ;
Hattori, Y ;
Sakurai, M ;
Hasegawa, I ;
Ozasa, T ;
Kanie, F ;
Kano, H ;
Ueda, R ;
Mizokami, M .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (12) :1343-1347
[9]
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals [J].
Gandhi, RT ;
Wurcel, A ;
Lee, H ;
McGovern, B ;
Boczanowski, M ;
Gerwin, R ;
Corcoran, CP ;
Szczepiorkowski, Z ;
Toner, S ;
Cohen, DE ;
Sax, PE ;
Ukomadu, C .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) :1602-1605
[10]
Grob P, 2000, J MED VIROL, V62, P450, DOI 10.1002/1096-9071(200012)62:4&lt